|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of internally developed software | |||||
| Amortization of intangible assets | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Loss on debt extinguishment | |||||
| Impairment charges | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract assets – commissions receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Accrued marketing expenses | |||||
| Deferred revenue | |||||
| Accrued expenses and other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Capitalized internal-use software and website development costs | |||||
| Purchases of property and equipment and other assets | |||||
| Purchases of marketable securities | |||||
| Proceeds from redemption and maturities of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Net proceeds from debt financing | |||||
| Payment of debt issuance costs | |||||
| Repayment of term loan credit facility | |||||
| Proceeds from revolving credit facility, net of costs | |||||
| Payments of deferred financing costs | |||||
| Net proceeds from exercise of common stock options and employee stock purchases | |||||
| Repurchase of shares to satisfy employee tax withholding obligations | |||||
| Principal payments in connection with leases | |||||
| Payments of preferred stock dividends | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flows | |||||
| Cash paid for interest | |||||
| Cash payments for income taxes, net | |||||
Loading...